Company Description

23andMe is a leading consumer genetics and research company. The mission of the company is to help people access, understand and benefit from the human genome. On Mar. 23, 2025, 23andMe Initiated Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process.